St. Elisabeth-Krankenhaus Köln-Hohenlind


Köln, Germany

Publications in cooperation with FAU scientists

Eckstein, M., Wirtz, R.M., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget, 9(19), 15001-15014.
Zinnall, U., Weyerer, V., Compérat, E., Camparo, P., Gaisa, N.T., Knuechel-Clarke, R.,... Bertz, S. (2018). Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. Human Pathology.
Eckstein, M., Wirtz, R.M., Gross-Weege, M., Breyer, J., Otto, W., Stoehr, R.,... Erben, P. (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. International Journal of Molecular Sciences, 19(11).
Breyer, J., Otto, W., Wirtz, R.M., Wullich, B., Keck, B., Erben, P.,... Hartmann, A. (2017). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis, 98(3), 282-289.
Breyer, J., Wirtz, R.M., Otto, W., Erben, P., Kriegmair, M.C., Stoehr, R.,... Hartmann, A. (2017). In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Archiv, 470(3), 267-274.
Breyer, J., Wirtz, R.M., Otto, W., Laible, M., Schlombs, K., Erben, P.,... Hartmann, A. (2017). Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies. Oncotarget, 8(40), 67684-67695.
Otto, W., Breyer, J., Herdegen, S., Eder, F., Bertz, S., May, M.,... Hartmann, A. (2017). WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach. International Urology and Nephrology, 49(3), 431-437.
Breyer, J., Wirtz, R.M., Laible, M., Schlombs, K., Erben, P., Kriegmair, M.C.,... Otto, W. (2016). ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). Virchows Archiv, 469(5), 547-552.
Wirtz, R.M., Fritz, V., Stoehr, R., & Hartmann, A. (2016). Molecular classification of bladder cancer. Possible similarities to breast cancer. Pathologe, 37(1), 52-60.
Laible, M., Schlombs, K., Kaiser, K., Veltrup, E., Herlein, S., Lakis, S.,... Sahin, U. (2016). Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer, 16, 398.

Last updated on 2017-22-07 at 06:24